ODAN-DEXAMETHASONE ELIXIR 0.5 MG / 5 ML
DEXAMETHASONE : 0.5 MG / 5 ML · DIN 02528584 · ODAN LABORATORIES LTD
Health Canada status: MARKETED
What is ODAN-DEXAMETHASONE ELIXIR?
ODAN-DEXAMETHASONE ELIXIR 0.5 MG / 5 ML contains DEXAMETHASONE : 0.5 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02528584, held by ODAN LABORATORIES LTD, supplied as ELIXIR for ORAL administration. Health Canada currently lists it as marketed, status dated 25-Nov-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ODAN-DEXAMETHASONE ELIXIR used for?
Odan - DEXAMETHASONE ELIXIR (dexamethasone elixir) is used orally in the management of disorders responsive to adrenocortical hormone therapy such as allergic states, rheumatic disorders, dermatologic diseases, ophthalmic diseases, endocrine disorders, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, cerebral edema, gastrointestinal diseases, tuberculous meningitis, trichinosis, systemic lupus erythematosus, acute rheumatic carditis, and for diagnostic testing of adrenocortical hyperfunction, and antiemetic effect for chemotherapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02528584 |
|---|---|
| Brand name | ODAN-DEXAMETHASONE ELIXIR |
| Generic / active ingredient | DEXAMETHASONE : 0.5 MG / 5 ML |
| Manufacturer | ODAN LABORATORIES LTD |
| Strength | 0.5 MG / 5 ML |
| Dosage form | ELIXIR |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | H02AB02 DEXAMETHASONE |
| AHFS class | 90:28.28.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-Nov-2022 |
How is it stored and handled?
null
How is it supplied?
bottles of 100 mL
Is DEXAMETHASONE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by STERIMAX INC (Tier 3 shortage DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP" aria-label="Actual Tier 3 shortage DEXAMETHASONE SODIUM P), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code H02AB02 DEXAMETHASONE. 13 of 42 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-DEXAMETHASONE | 0.5 MG | TABLET | APOTEX INC | MARKETED | DIN 02261081 |
| APO-DEXAMETHASONE | 4 MG | TABLET | APOTEX INC | MARKETED | DIN 02250055 |
| DEXAMETHASONE OMEGA UNIDOSE | 10 MG / 1 ML | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02387743 |
| DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP | 10 MG / 1 ML | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00874582 |
| DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML | 4 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00664227 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP | 4 MG/ML | SOLUTION | STERIMAX INC | MARKETED | DIN 01977547 |
| DEXAMETHASONE-OMEGA | 10 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02204274 |
| DEXAMETHASONE-OMEGA | 4 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02204266 |
| PMS-DEXAMETHASONE | 0.5 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 01964976 |
| PMS-DEXAMETHASONE | 2 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02279363 |
Who else supplies DEXAMETHASONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DEXAMETHASONE appears in 2222 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.